Diagnosing Acute Bacterial vs Viral Rhinosinusitis
American Family Physician Community Blog, Diagnosing Acute Bacterial vs Viral Rhinosinusitis, written by Lilian White, MD.
Related Articles
Focusing Treatment on Multiple Pathways to Reduce Resistance and Improve Outcomes in Triple-Positive Breast Cancer
Using new treatment advances, traditional medications, genetic profiles, immunotherapies, and individualized plans enables providers to improve outcomes for patients with TPBC.
How Safe Is Metformin in Stage 4 Chronic Kidney Disease?
Metformin is excreted renally and is contraindicated (according to U.S. prescribing information) in patients with estimated glomerular filtration rates
Low-Dose Vaccination for Yellow Fever in Adults | NEJM
Quick Take Video Summary from The New England Journal of Medicine — Low-Dose Vaccination for Yellow Fever in Adults
Dermatology Books, eBooks & Journals | US Elsevier Health
Shop the latest in Dermatology from authors such as Bolognia and Habif, covering clinical dermatology, dermoscopy, & dermatopathology + free shipping!
How can parents’ experience of child death reviews be improved?
When my sister died through suicide—as an adult, but still my little sister—I, my parents and our family and friends all grappled with that persistent…
FDA Grants Fast Track Designation to 67Cu-SAR-bisPSMA for Prostate Cancer
67Cu-SAR-bisPSMA is indicated for adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC).
Researchers could soon access GP patient data—how will it work?
Nearly 18 months after NHS England announced its intention to allow scientists to analyse general practice data for research, the scheme finally looks set to…
Immunology | bioRxiv
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
Video: Etranacogene Dezaparvovec Has Long-Term Efficacy, Can Expand Eligibility for Hemophilia B
Steven Pipe, MD, explains the long-term efficacy data surrounding etranacogene dezaparvovec in patients with hemophilia B.
Enhancing Outcomes With Immunotherapy Agents for Patients With Non-Muscle Invasive Bladder Cancer
Panelists at the 2025 ASCO Genitourinary Cancers Symposium discussed challenges and new approaches to treatment.